Olympus Corporation

Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business

Thursday, April 8, 2021 - 2:00am

Olympus opens global headquarters for Therapeutic Solutions and Medical Business in Westborough, MA, U.S.

Key Points: 
  • Olympus opens global headquarters for Therapeutic Solutions and Medical Business in Westborough, MA, U.S.
  • Since the Transform Olympus initiatives were unveiled in 2019, many U.S.-based executives have been leading TSD growth; Olympus has dramatically expanded the business with acquisitions, as well as through organic growth.
  • The facility will serve as one of several R&D hubs for Olympus, while enabling coordinated and agile management processes to support a global medical technology enterprise.
  • Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications.

Olympus Announces Global Image of the Year Award Winners

Wednesday, April 7, 2021 - 1:30pm

WALTHAM, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Olympus unveiled the winners of their second Global Image of the Year Life Science Light Microscopy Award , an annual competition that recognizes the best in life science imaging.

Key Points: 
  • WALTHAM, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Olympus unveiled the winners of their second Global Image of the Year Life Science Light Microscopy Award , an annual competition that recognizes the best in life science imaging.
  • Werner Zuschratter from Germany was selected as the global winner for his eye-catching image of a whole rat embryo captured with a confocal microscope.
  • Olympus IOTY Award began in 2017 as the Image of the Year European Life Science Light Microscopy Award with the aim to celebrate both the artistic and scientific value of microscopy images.
  • Olympus and the Olympus logo are trademarks of Olympus Corporation or its subsidiaries.

Olympus Files Patent Infringement Lawsuit Against Cantel/Medivators

Monday, March 22, 2021 - 11:48pm

CENTER VALLEY, Pa., March 22, 2021 /PRNewswire/ -- Today, Olympus Corporation of the Americas announced its filing of litigation in which Olympus accuses Cantel/Medivators of violating patents related to colonoscopy assist devices.

Key Points: 
  • CENTER VALLEY, Pa., March 22, 2021 /PRNewswire/ -- Today, Olympus Corporation of the Americas announced its filing of litigation in which Olympus accuses Cantel/Medivators of violating patents related to colonoscopy assist devices.
  • The complaint alleges that the manufacture, sale and distribution of the AmplifEye Endoscopic Device infringes on two patents held by Olympus for its ENDOCUFF single-use devices.
  • This lawsuit follows the finding by the High Court of Justice England and Wales, Patent Court that the ENDOCUFF and ENDOCUFF VISION UK national and UK(EP) patents (as amended) were infringed by the AmplifEyeTM Endoscopic Device.
  • The family of ENDOCUFF products and the patents that protect those products were fully acquired in summer 2020 with the Olympus acquisition of Arc Medical Design.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of CBLI, NEBC, THCB, and FTOC Mergers

Tuesday, February 16, 2021 - 10:57pm

WILMINGTON, Del., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A.

Key Points: 
  • WILMINGTON, Del., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A.
  • FTAC Olympus Acquisition Corporation (NASDAQ CM: FTOC ) regarding possible breaches of fiduciary duties and other violations of law related to FTACs agreement to merge with Payoneer Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-ftac-olympus-acquisition-corporation .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com .
  • , with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of FTAC Olympus Acquisition Corporation Merger

Wednesday, February 3, 2021 - 10:24pm

WILMINGTON, Del., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A.

Key Points: 
  • WILMINGTON, Del., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A.
  • announces that it is investigating FTAC Olympus Acquisition Corporation (FTAC) (NASDAQ CM: FTOC ) regarding possible breaches of fiduciary duties and other violations of law related to FTACs agreement to merge with Payoneer Inc.
    To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-ftac-olympus-acquisition-corporation .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com .
  • Rigrodsky Law, P.A.

Olympus PneumoLiner Is the Only 510(k)-Cleared Containment Device for Morcellation of Gynecological Tissue, as Recommended by the FDA

Wednesday, February 3, 2021 - 2:17pm

"ii, iii

Key Points: 
  • "ii, iii
    Indications for use have also been clarified to reflect those women who can be appropriately treated using contained morcellation.
  • From the time of the PneumoLiner's DeNovo clearance in 2016, Olympus has sold its PK Morcellator only together with the containment system.
  • In addition, Olympus has made the PneumoLiner available to physicians choosing an alternate to the Olympus morcellator, provided there was device compatibility.
  • i FDA allows marketing of first-of-kind tissue containment system for use with certain laparoscopic power morcellators in select patients.

Payoneer to Become Publicly Traded Company Through Combination With FTAC Olympus Acquisition Corporation

Wednesday, February 3, 2021 - 1:00pm

Upon closing of the reorganization, the newly created holding company will be renamed Payoneer Global Inc. and the combined company (the "Company") will operate as Payoneer, a U.S. publicly listed entity.

Key Points: 
  • Upon closing of the reorganization, the newly created holding company will be renamed Payoneer Global Inc. and the combined company (the "Company") will operate as Payoneer, a U.S. publicly listed entity.
  • Payoneer services include: Marketplace Payments; B2B Accounts Payable / Accounts Receivable; Merchant Services; Working Capital; and Risk and Compliance Services.
  • Betsy Z. Cohen, Chairman of the Board of Directors of FTAC Olympus Acquisition Corp., said, "Payoneer is at the forefront of the rapid, global shift to digital commerce across all sectors.
  • In connection with the proposed Reorganization between Payoneer and FTAC Olympus Acquisition Corp., Payoneer Global Inc. intends to file with the SEC a preliminary proxy statement / prospectus and will mail a definitive proxy statement / prospectus and other relevant documentation to FTAC Olympus Acquisition Corp. stockholders.

Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities

Wednesday, January 27, 2021 - 10:30pm

Tokyo / Hamburg, Jan 28, 2021 - (ACN Newswire) - Olympus Corporation (Olympus - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. (Quest - CEO: Richard Meester) for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.

Key Points: 
  • Tokyo / Hamburg, Jan 28, 2021 - (ACN Newswire) - Olympus Corporation (Olympus - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. (Quest - CEO: Richard Meester) for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.
  • Headquartered in the Netherlands, Quest offers advanced fluorescence imaging systems (FIS) for the medical field, enabling more surgical endoscopy capabilities, compared to conventional imaging technologies.
  • Kanichi Matsumoto, global head of Surgical Endoscopy at Olympus, said: "We are delighted to incorporate Quest's advanced FIS capabilities into our comprehensive medical imaging portfolio.
  • Quest Photonic Devices B.V. is a multispectral imaging leader and focuses on the medical markets of fluorescence image-guided surgery and cancer-targeted probes.

Olympus and Hitachi Announce Long-Term Business Alliance regarding Endoscopic Ultrasound Systems

Wednesday, January 6, 2021 - 9:48am

TOKYO, Jan 6, 2021 - (JCN Newswire) - Olympus Corporation (TSE:7733) and Hitachi, Ltd. (TSE:6501) have signed a five-year contract to jointly develop Endoscopic Ultrasound Systems (EUS).

Key Points: 
  • TOKYO, Jan 6, 2021 - (JCN Newswire) - Olympus Corporation (TSE:7733) and Hitachi, Ltd. (TSE:6501) have signed a five-year contract to jointly develop Endoscopic Ultrasound Systems (EUS).
  • Hitachi will also continue to supply diagnostic ultrasound systems and related parts used in EUS to Olympus under this contract.
  • Hironobu Kawano, Division Head of the Endoscopic Solutions Division, Olympus Corporation, said, "Olympus aims to improve patients' quality of life through early diagnosis made available with Endoscopic Ultrasound Systems.
  • Toshihiko Kawano, CTO of Healthcare Business Unit, Hitachi, Ltd., said, "It is our pleasure to continue our collaboration with Olympus in the EUS business.